Home / Nervous system / Lamotrigine
ATC N03AX09 · Antiepileptics
Lamotrigine shortage
As of 31 Oct 2026, Lamotrigine has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 6 products.
Countries3/5
Products6packs or presentations
Short since29 Jun 20264 months ago
Earliest return31 Oct 2026company estimate
No return date4products
Main reasonActive ingredient shortage
Timeline
ItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | LAMOTRIGINA EG | EG S.P.A. | 1 Jul 2026 | not given | Increased demand Elevata richiesta |
| ES | LAMOTRIGINA VIATRIS 100 MG COMPRIMIDOS DISPERSABLES/MASTICABLES EFG, 56 comprimidos | Viatris Pharmaceuticals S.L. | 5 Oct 2026 | 26 Nov 2026 | Not stated |
| AT | Lamotrigin 1A Pharma 25 mg - lösliche Tabletten, 30 Stück | 1 A Pharma GmbH | 29 Jun 2026 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Lamotrigin 1A Pharma 50 mg - lösliche Tabletten, 30 Stück | 1 A Pharma GmbH | 1 Sep 2026 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Lamotrigin Sandoz GmbH 25 mg - lösliche Tabletten, 30 Stück | Sandoz GmbH | 7 Sep 2026 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Lamictal 100 mg Tabletten (kaubar/suspendierbar), 50 Stück | Glaxosmithkline Pharma GmbH | 2 Oct 2026 | 31 Oct 2026 | Increased demand Erhöhter Mehrbedarf |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.